Active Ingredient (In Each Dose)
Polyethylene Glycol 3350, 17 g
The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Polyethylene Glycol 3350 (NDC 0904-6931). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each dose), purpose, use, warnings, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Polyethylene Glycol 3350, 17 g
Osmotic Laxative
Allergy alert: Do not use if you are allergic to polyethylene glycol
if you have kidney disease, except under the advice and supervision of a doctor
taking a prescription drug
you may have loose, watery, more frequent stools
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
none
(800) 616-2471
NDC 0904-6931-26
Compare to MiraLAX® active ingredient*
MAJOR®
PEG3350
Polyethylene Glycol 3350
Powder for Oral Solution
Osmotic Laxative
• Relieves Occasional Constipation (Irregularity)
• Softens Stool
Dissolves in Any Beverage
Sugar Free
14 Once-Daily Doses
NET WT 0.5 OZ (17 g) Each
*This product is not manufactured or distributed by Bayer Healthcare LLC, owner of the registered trademark MiraLAX®.
Distributed by MAJOR® PHARMACEUTICALS
17177 N Laurel Park Drive, Suite 233
Livonia, MI 48152
Product of India
Rev. 12/20 M-17
Re-order No. 701066
50844 REV0719B72648
* Please review the disclaimer below.